OPTIMAL MANAGEMENT OF ATEZOLIZUMAB PLUS BEVACIZUMAB THERAPY FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA FOCUSING ON THERAPEUTIC MODIFICATIONS

被引：0
|
作者：
Tokunaga, Takayuki [1 ]
Tateyama, Masakuni [1 ]
Kondo, Yasuteru [2 ,3 ]
Miuma, Satoshi [4 ]
Miyase, Shiho [5 ]
Tanaka, Kentaro [1 ]
Narahara, Satoshi [1 ]
Inada, Hiroki [1 ]
Kurano, Sotaro [1 ]
Yoshimaru, Yoko [1 ]
Nagaoka, Katsuya [1 ]
Watanabe, Takehisa [1 ]
Setoyama, Hiroko [1 ]
Tanaka, Yasuhito [1 ]
机构：
[1] Kumamoto Univ, Dept Gastroenterol & Hepatol, Fac Life Sci, Kumamoto, Japan
[2] Sendai Kousei Hosp, Hepatol, Sendai, Japan
[3] Sendai Kousei Hosp, Sendai, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki, Japan
[5] Kumamoto Shinto Gen Hosp, Dept Gastroenterol & Hepatol, Kumamoto, Japan
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4461
引用
收藏
页码：S1351 / S1352
页数：2
相关论文
共 50 条
  • [1] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Qin, Shukui
    Ikeda, Masafumi
    Galle, Peter R.
    Ducreux, Michel
    Kim, Tae-You
    Kudo, Masatoshi
    Breder, Valeriy
    Merle, Philippe
    Kaseb, Ahmed O.
    Li, Daneng
    Verret, Wendy
    Xu, Derek-Zhen
    Hernandez, Sairy
    Liu, Juan
    Huang, Chen
    Mulla, Sohail
    Wang, Yulei
    Lim, Ho Yeong
    Zhu, Andrew X.
    Cheng, Ann-Lii
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1894 - 1905
  • [2] Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
    Lee, Kyung-Hun
    Lee, Michael S.
    [J]. LANCET ONCOLOGY, 2020, 21 (09): : E413 - E413
  • [3] Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
    Maesaka, Kazuki
    Sakamori, Ryotaro
    Yamada, Ryoko
    Tahata, Yuki
    Imai, Yasuharu
    Ohkawa, Kazuyoshi
    Miyazaki, Masanori
    Mita, Eiji
    Ito, Toshifumi
    Hagiwara, Hideki
    Yakushijin, Takayuki
    Kodama, Takahiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    [J]. HEPATOLOGY RESEARCH, 2022, 52 (03) : 298 - 307
  • [4] Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma
    D'Alessio, Antonio
    Cammarota, Antonella
    Zanuso, Valentina
    Pressiani, Tiziana
    Personeni, Nicola
    Rimassa, Lorenza
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (09) : 927 - 939
  • [5] Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Moris, Dimitrios
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 637 - 638
  • [6] Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
    Tokunaga, Takayuki
    Tateyama, Masakuni
    Kondo, Yasuteru
    Miuma, Satoshi
    Miyase, Shiho
    Tanaka, Kentaro
    Narahara, Satoshi
    Inada, Hiroki
    Kurano, Sotaro
    Yoshimaru, Yoko
    Nagaoka, Katsuya
    Watanabe, Takehisa
    Setoyama, Hiroko
    Fukubayashi, Kotaro
    Tanaka, Motohiko
    Tanaka, Yasuhito
    [J]. CANCERS, 2023, 15 (05)
  • [7] Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma
    Yamaba, Shinpei
    Imai, Yukinori
    Sugawara, Kayoko
    Uchida, Yoshihito
    Fuchigami, Akira
    Uchiya, Hiroshi
    Nakayama, Nobuaki
    Mochida, Satoshi
    [J]. PLOS ONE, 2024, 19 (04):
  • [8] Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
    Yano, Shigeki
    Kawaoka, Tomokazu
    Yamasaki, Shintaro
    Johira, Yusuke
    Kosaka, Masanari
    Shirane, Yuki
    Miura, Ryoichi
    Amioka, Kei
    Naruto, Kensuke
    Yamaoka, Kenji
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Fujino, Hatsue
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Miki, Daiki
    Tsuge, Masataka
    Teraoka, Yuji
    Kouno, Hirotaka
    Takaki, Shintaro
    Mori, Nami
    Tsuji, Keiji
    Oka, Shiro
    [J]. CANCERS, 2023, 15 (22)
  • [9] The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
    Esmail, Abdullah
    Xu, Jiaqiong
    Burns, Ethan A.
    Abboud, Karen
    Sheikh, Ali
    Umoru, Godsfavour
    Gee, Kelly
    Wiechmann, Catherine
    Zhang, Yuqi
    Abdelrahim, Maen
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [10] Current Role of Atezolizumab Plus Bevacizumab Therapy in the Sequential Treatment of Unresectable Hepatocellular Carcinoma
    Komatsu, Shohei
    Yano, Yoshihiko
    Fujishima, Yoshimi
    Ishida, Jun
    Kido, Masahiro
    Kuramitsu, Kaori
    Yamamoto, Atsushi
    Goto, Tadahiro
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Ueda, Yoshihide
    Kodama, Yuzo
    Fukumoto, Takumi
    [J]. ANTICANCER RESEARCH, 2022, 42 (03) : 1403 - 1412
12345